ClinicalTrials.Veeva

Menu

Prognostic Score in Covid-19

U

University of L'Aquila

Status

Completed

Conditions

Covid19 Prognostic Parameters

Treatments

Other: data collection

Study type

Observational

Funder types

Other

Identifiers

NCT04780373
prot. N. 71726

Details and patient eligibility

About

The aim of the study is to define the clinical and biochemical parameters that characterize COVID-19 patients with a negative prognostic evolution. Our clinical score will be capable to recognize patient with favorable prognosis or patient with poor prognosis by statistical data analysis.

Enrollment

200 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients over 18 and symptomatic and positive for COVID-19 by polymerase chain reaction assay for rhino-pharingeal swab

Exclusion criteria

  • Under 18

Trial design

200 participants in 2 patient groups

Development cohort
Treatment:
Other: data collection
Validation cohort
Treatment:
Other: data collection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems